AI assistant
Sending…
Tempest Therapeutics, Inc. — Director's Dealing 2021
Jul 14, 2021
34632_dirs_2021-07-14_ae30e137-fe6e-419a-a812-3532645ae295.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Tempest Therapeutics, Inc. (TPST)
CIK: 0001544227
Period of Report: 2021-07-12
Reporting Person: Maestas Nicholas (VP of Strategy and Finance)
More from Tempest Therapeutics, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Mar 31
Annual Report
2026
Mar 30